Literature DB >> 23681176

[Suture-free amniotic membrane transplantation].

K Engelmann1, I Kotomin, A Knipper, C Werner.   

Abstract

Amniotic membrane transplantation has been used very successfully in ophthalmology since the 1940s for treatment of surface disorders. Over the course of the years the indications for use have been continuously extended. In contrast the operative technique is predominantly invasive, i.e. the amniotic membrane is surgically sutured onto the surface of the eye. In order to avoid surgical trauma the authors have developed a device which allows the amniotic membrane to be stretched in a ring and the amniotic ring can then be placed suture-free on the eye surface. The authors are hopeful that the biological principle of the amniotic membrane can be better utilized by uncomplicated repetitive application.

Entities:  

Mesh:

Year:  2013        PMID: 23681176     DOI: 10.1007/s00347-012-2742-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  29 in total

1.  The effect of long-term storage on the biological and histological properties of cryopreserved amniotic membrane.

Authors:  H Thomasen; M Pauklin; B Noelle; G Geerling; J Vetter; P Steven; K-P Steuhl; D Meller
Journal:  Curr Eye Res       Date:  2011-01-28       Impact factor: 2.424

2.  Simultaneous amniotic membrane patch in high-risk keratoplasty.

Authors:  Berthold Seitz; Sujata Das; Renate Sauer; Carmen Hofmann-Rummelt; Matthias W Beckmann; Friedrich E Kruse
Journal:  Cornea       Date:  2011-03       Impact factor: 2.651

3.  Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.

Authors:  Darren G Gregory
Journal:  Ophthalmology       Date:  2011-03-26       Impact factor: 12.079

4.  The effect of human amniotic membranes on the bacteria population of infected rat burns.

Authors:  M C Robson; T J Krizek
Journal:  Ann Surg       Date:  1973-02       Impact factor: 12.969

5.  Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells.

Authors:  M Adinolfi; C A Akle; I McColl; A H Fensom; L Tansley; P Connolly; B L Hsi; W P Faulk; P Travers; W F Bodmer
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

6.  Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix.

Authors:  A Solomon; M Rosenblatt; D Monroy; Z Ji; S C Pflugfelder; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 7.  Surgery of the cornea: corneal, limbal stem cell and amniotic membrane transplantation.

Authors:  F E Kruse; C Cursiefen
Journal:  Dev Ophthalmol       Date:  2008

8.  Immunogenicity of human amniotic epithelial cells after transplantation into volunteers.

Authors:  C A Akle; M Adinolfi; K I Welsh; S Leibowitz; I McColl
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

9.  Evaluation of the role of ProKera in the management of ocular surface and orbital disorders.

Authors:  Gowri Pachigolla; Pawan Prasher; Mario A Di Pascuale; James P McCulley; John G McHenry; V Vinod Mootha
Journal:  Eye Contact Lens       Date:  2009-07       Impact factor: 2.018

10.  Suppression of corneal neovascularization by PEDF release from human amniotic membranes.

Authors:  Chunkui Shao; Jing Sima; Sarah X Zhang; Ji Jin; Peter Reinach; Zheng Wang; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.